Ojer Pharma Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.19M

  • Investors
  • 9

Ojer Pharma General Information

Description

Operator of pharmaceutical products intended to offer therapeutic dermatological alternatives to patients. The company offers various dermatological medicines and products that meet the needs of patients internationally, enabling patients to avail themselves of bioadhesive products with competitive advantages.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sancho el Mayor 2, 1º Izda
  • 31002 Pamplona
  • Spain
+34 948
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Sancho el Mayor 2, 1º Izda
  • 31002 Pamplona
  • Spain
+34 948

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ojer Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 19-Mar-2023 $3.19M Completed Generating Revenue
6. Later Stage VC 01-Jul-2020 Completed Generating Revenue
5. Later Stage VC (Series A) 01-Oct-2019 Completed Generating Revenue
4. Later Stage VC 17-Jul-2014 Completed Generating Revenue
3. Later Stage VC 02-Jun-2011 Completed Generating Revenue
2. Early Stage VC 29-Jun-2007 $671K $671K Completed Generating Revenue
1. University Spin-Out 01-Jan-2005 Completed Generating Revenue
To view Ojer Pharma’s complete valuation and funding history, request access »

Ojer Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 248,500 $0.011253 $2.26 $2.26 1x $2.26 15.8%
Ordinary 388,600 $0.011253 $1.25 $1.25 1x $1.25 24.7%
To view Ojer Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ojer Pharma Patents

Ojer Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2013363788-A1 Gel compositions Active 17-Dec-2012
AU-2013363788-B2 Gel compositions Active 17-Dec-2012
CA-2893656-A1 Gel compositions Active 17-Dec-2012
CA-2893656-C Gel compositions Active 17-Dec-2012
EP-2742932-A1 Gel compositions Inactive 17-Dec-2012 A61K9/0014
To view Ojer Pharma’s complete patent history, request access »

Ojer Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ojer Pharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Vegal Farmacéutica Corporation Minority
Easo Ventures Venture Capital Minority
Fundacion Cajanavarra Limited Partner Minority
University Foundation of Navarre Other Minority
Inveready Asset Management Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ojer Pharma FAQs

  • When was Ojer Pharma founded?

    Ojer Pharma was founded in 2005.

  • Where is Ojer Pharma headquartered?

    Ojer Pharma is headquartered in Pamplona, Spain.

  • What is the size of Ojer Pharma?

    Ojer Pharma has 18 total employees.

  • What industry is Ojer Pharma in?

    Ojer Pharma’s primary industry is Pharmaceuticals.

  • Is Ojer Pharma a private or public company?

    Ojer Pharma is a Private company.

  • What is Ojer Pharma’s current revenue?

    The current revenue for Ojer Pharma is .

  • How much funding has Ojer Pharma raised over time?

    Ojer Pharma has raised $7.46M.

  • Who are Ojer Pharma’s investors?

    Vegal Farmacéutica, Easo Ventures, Fundacion Cajanavarra, University Foundation of Navarre, and Inveready Asset Management are 5 of 9 investors who have invested in Ojer Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process